NGM282 NASH

A phase 2b, randomized, double-blind, placebo-controlled, multi-center study to evaluate the efficacy, safety, and tolerability of two doses of NGM282 administered for 24 weeks for the treatment of histologically confirmed Non-alcoholic Steatohepatitis (NASH).

Please complete the form below if you are interested in joining a clinical study. Please note that not all who apply are accepted into a trial.

Fields marked with an * are required

Newsletter

Sign up with your name and email address to obtain ongoing updates. Please know that you can ‘opt out’ at any time.

Get In Touch

We’d love to hear from you!

Excel Medical Clinical Trials LLC
7900 Glades Road, Suite 400
Boca Raton, FL 33434